
epidote.in provides affordable, genomics-based diagnostics for infectious diseases in India using sequencing and machine learning. It combines next-generation sequencing with single-cell immunophenotyping, transcriptomics, and epigenetic analysis to map disease progression and prognosis, including eco-friendly antigen design such as artificial venom constructs. The company operates in translational biotech, focusing on B2B collaborations with healthcare labs, research institutions, and government programs. It targets rural and developing regions, aiming to lower costs and increase test accessibility through scalable NGS workflows. The technology foundation includes NGS, ML, single-cell analysis, epigenetics, and proteomics to enable broad diagnostic and research applications.

epidote.in provides affordable, genomics-based diagnostics for infectious diseases in India using sequencing and machine learning. It combines next-generation sequencing with single-cell immunophenotyping, transcriptomics, and epigenetic analysis to map disease progression and prognosis, including eco-friendly antigen design such as artificial venom constructs. The company operates in translational biotech, focusing on B2B collaborations with healthcare labs, research institutions, and government programs. It targets rural and developing regions, aiming to lower costs and increase test accessibility through scalable NGS workflows. The technology foundation includes NGS, ML, single-cell analysis, epigenetics, and proteomics to enable broad diagnostic and research applications.